What an epic start to 2022. In just one quarter we are now in the amidst of the Perfect Long Storm, Russian-Ukraine Tension and Will Smith slapping Chris Rock. Maybe the saving grace is that we will be able to travel to Malaysia (with more freedom) from 1st April.
In any case, this is the SRS update for March 2022. If you are new to SRS, I would encourage you to start from my most read SRS article, 5 Things You Need To Know About SRS to begin.
Disclaimer: This is not and should not be taken as a buy/sell recommendation.
My Thoughts And Consideration
The most glaring underperformance continues to be my exposure into Chinese Technology Stocks (SGX:HST). The price is already 41% down since the last time I entered. The question I get asked frequently is how will China do moving ahead.According to Political Bureau of the Communist Party of China (CPC) Central Committee meeting on Dec 2021, the focus on 2022 will be prioritize stability while pursuing progress. This is a great difference from their focus of strengthening antimonopoly rules in 2021. I believe this might be a turning point and am considering a Dollar Cost Averaging into SGX:HST. This is after a capital injection into the SRS for tax purpose.
Final Thoughts
I reemphasize again that this is not and should not be taken as a buy/sell recommendation. Wishing you all the best!
Chengkok is a licensed Financial Services Consultant since 2012. He is an Investment and Critical Illness Specialist. Wealthdojo was created in 2019 to educate and debunk “free financial advice” that was given without context.
Feel Free To Reach Out To Share Your Thoughts.
Contact: 94316449 (Whatsapp) chengkokoh@gmail.com (Email)
Telegram: Wealthdojo [Continuous Learning Channel]
Reviews: About Me
The views and opinions expressed in this publication are those of the author and do not reflect the official policy or position of any other agency, organisation, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author.
[…] However, they are all now NOT adding into new positions as the market is still going down. DCA is somewhat easy to say but not easy to execute consistently unless there is a system that is set up. Personally, I have averaged down on the China Market previously and it is still a bleeding position (Check out my latest SRS positions). […]